SEK72.60
1.54% yesterday
Stockholm, Sep 27, 05:29 pm CET
ISIN
SE0000163628
Symbol
EKTA B
Sector

Elekta AB Stock price

SEK72.60
+3.55 5.14% 1M
-8.22 10.17% 6M
-9.72 11.81% YTD
-1.18 1.60% 1Y
-28.45 28.15% 3Y
-56.01 43.55% 5Y
+1.65 2.32% 10Y
Stockholm, Closing price Fri, Sep 27 2024
+1.10 1.54%
ISIN
SE0000163628
Symbol
EKTA B
Sector

Key metrics

Market capitalization SEK27.32b
Enterprise Value SEK32.70b
P/E (TTM) P/E ratio 24.09
EV/FCF (TTM) EV/FCF 14.54
EV/Sales (TTM) EV/Sales 1.81
P/S ratio (TTM) P/S ratio 1.51
P/B ratio (TTM) P/B ratio 2.55
Dividend yield 3.36%
Last dividend (FY23) SEK2.40
Revenue growth (TTM) Revenue growth 4.29%
Revenue (TTM) Revenue SEK18.12b
EBIT (operating result TTM) EBIT SEK2.21b
Free Cash Flow (TTM) Free Cash Flow SEK2.25b
Cash position SEK2.36b
EPS (TTM) EPS SEK2.97
P/E forward 18.31
P/S forward 1.46
EV/Sales forward 1.75
Show more

Is Elekta AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Elekta AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Elekta AB forecast:

4x Buy
25%
5x Hold
31%
7x Sell
44%

Analyst Opinions

16 Analysts have issued a Elekta AB forecast:

Buy
25%
Hold
31%
Sell
44%

Financial data from Elekta AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jul '24
+/-
%
18,117 18,117
4% 4%
100%
- Direct Costs 11,544 11,544
8% 8%
64%
6,573 6,573
2% 2%
36%
- Selling and Administrative Expenses 2,280 2,280
6% 6%
13%
- Research and Development Expense 1,454 1,454
3% 3%
8%
2,839 2,839
1% 1%
16%
- Depreciation and Amortization 629 629
6% 6%
3%
EBIT (Operating Income) EBIT 2,210 2,210
3% 3%
12%
Net Profit 1,135 1,135
1% 1%
6%

In millions SEK.

Don't miss a Thing! We will send you all news about Elekta AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Elekta AB is a medical technology company. It engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. Elekta operates through the following geographical segments: North and South America; Europe, Middle East and Africa; and Asia Pacific. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden.

Head office Sweden
CEO Gustaf Salford
Employees 4,641
Founded 1972
Website www.elekta.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today